California subpoenas J & J unit over drug

Los Angeles Times

From Bloomberg News

Johnson & Johnson’s Janssen unit received a subpoena from the California attorney general’s office over sales and marketing of Risperdal, a schizophrenia drug.

The subpoena was issued in September, Johnson & Johnson said in a regulatory filing. The New Brunswick, N.J.-based company said it was responding.

California authorities asked for documents on “sales and marketing and side effects” of the drug, as well as on “interactions with state officials” in Medicaid, the health insurance program for the poor, the filing said.

J&J shares fell 72 cents to $67.99.


Leave a comment

Filed under Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s